Sci Forschen Inc.
2470-1009
Bi-Monthly
2015
14088162779
United States
English
YES
Google Scholar
info@sciforschenonline.org, varsham@umich.edu
Journal of Drug Research and Development (ISSN 2470-1009 ) presents up-to-date coverage of advanced drug systems and their innovative service to human health. Furthermore, it brings the latest developments in fast-paced areas such as new drug approvals, covering all aspects of theory, research and application of different disciplines about the effects of drugs on Preclinical and Clinical Pharmacology, drug discovery and design. The Editorial Committee actively pursues to be a leading source of vital knowledge by promoting excellence in the analysis of the molecules and pathways that fail or are destabilised during a dominant disorder and the interaction of these with chemical compounds and biologics. Moreover, it promotes discoveries that are anticipated to have the first impact on medication based therapeutics. Finally, it pursues the analysis and the opportune adaptation of that science to the needs of the drug discovery process. DRD aims at an audience of Chemists, Chemical Engineers, Biologists, Scientists, and Oncologists working in R&D of drugs and biologics. Also, it may prove appealing to Scientists in Drug Design and Discovery, those occupied on the development of new drugs and biologics committed to the most updated and meaningful progress in Pharmacological Engineering and Biotechnology. Core areas of interest of JDRD include vital improvements that result in a better understanding of molecular mechanisms, gene regulation in normal and diseased cells as well as susceptibility and outcome to oncogenic agents. Similarly, the journal has interest on the worth resulting from the research and application of multiple disciplines converging to medication innovation. The journal pursues contributions which prioritize merit, originality, practical worth, reduction to practice, accuracy, and appeal to the readership. Those working in the drug discovery and development field, researchers engaged at Immunotherapy, Pharmaceutics, Computational Drug-target Analysis, Pre-clinical and Clinical Pharmacology, studying medication-hormone receptor-immune system interactions, natural products evaluation, Pharmacokinetics, are contributors of articles to JDRD.
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!
Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.